https://www.home.saxo/en-mena/markets/stocks/solv-xnys
Solventum Corp. stock | Saxo Bank
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital...
solventum corpsaxo bankstock
https://www.marketshost.com/ai-score/us/solv
SOLV Stock Analysis 2026: SELL Rating (75%) | Solventum Corp
May 17, 2026 - SOLV stock: SELL rating (75% confidence). Solventum Corp fundamental analysis 2026. Revenue: $2.0B. EPS: $0.07. ROE: 0.3%. AI-powered SEC 10-K analysis.
stock analysissolventum corpsellrating